Stock screener

RYTM

Conviction 35HealthcareScan · Thu, Sep 24, 2026
Dragonfly doji

Rhythm Pharmaceuticals, Inc. (RYTM) closed at $98.34 (+0.10%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 43, -16.4% from its 52-week high, -6.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

RYTM$98.34+0.10%
ResistanceSupportVol 14Insider sell
63 bars
6
6
Vol MA14 692.79K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
RHYTHM PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.rhythmtx.com ↗
Price98.34
Change+0.10%
Gap+0.20%
Rel volume1.83×
Avg volume614.19K
Avg $ vol62.09M
SMA 20102.10
SMA 50106.54
SMA 20099.29
Price vs 50-7.69%
Price vs 200-0.95%
MA stackmixed
50/200 cross—
Supertrenddown · 109.03
RSI (14)39
MACD hist-0.25
MACD cross—
Stoch %K / %D25 / 23
ADX (14)26
+DI / −DI14 / 26
RSI divergence—
MACD divergence—
ATR %4.08%
ADR %3.84%
52w high117.62
52w low75.82
From 52w high-16.39%
Above 52w low+29.70%
New 52w highNo
SqueezeOff
Bollinger width15.34%
%B0.26
Donchian pos14.38%
Donchian high114.75
Donchian low95.59
AVWAP (52w high)99.10
vs AVWAP high-0.77%
AVWAP (52w low)98.46
vs AVWAP low-0.12%
OBV trendFlat
Chaikin MF (20)-0.23
Today vs 20d1.83×
Avg vol (14d)692.78K
Avg vol (20d)614.19K
Avg $ vol (20d)62.09M
Market cap6.77B
RS Rating43 / 99
RS 3m (vs SPY)-13.65%
RS 6m (vs SPY)-0.60%
RS line new highNo
Trend template2/8
Technical rank49.2
1 week-0.69%
1 month-13.24%
3 months-9.16%
6 months+16.21%
1 year-0.36%
YTD-6.35%
P/E-34.45
P/B65.75
P/S35.68
P/FCF-58.06
EPS-3.11
Div yield—
ROE-190.85%
ROA-44.95%
Debt/Eq1.03
Current3.45
EV/EBITDA-35.57
Gross margin—
Net margin-103.57%
Rev growth45.83%
EPS growth24.58%
Price target143.50
Target upside45.92%
Analyst ratingBuy
Institutional122.53%
Ent. value6.81B
Revenue71.25M
Net income-49.3M
Gross profit—
Free cash flow-116.63M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out68.53M
Employees414
ListedThu, Oct 5, 2017
Free float61.13M
Float %89.2%
Short interest10.3M
Days to cover21.9d
Short volume69.7%
Squeeze score91 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.73 vs −$0.81
Last surprise+9.9% beat
Setup gradeD
Conviction35 / 100
Pattern quality—
Tech rank49.2 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RYTM

All disclosures →
No recent disclosed trades by Congress in RYTM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RYTM · open-market 5 sells

InsiderSideShares
Joshi Manher
Chief Medical Officer · Restricted Stock Units · 2026-08-17
Grant25K
Joshi Manher
Chief Medical Officer · Stock Options (Right to Buy) · 2026-08-17
Grant50K
Garfield Alastair
Chief Scientific Officer · Common Stock · 2026-08-13
Sell1.56K
Garfield Alastair
Chief Scientific Officer · Common Stock · 2026-08-13
Sell3.4K
Garfield Alastair
Chief Scientific Officer · Common Stock · 2026-08-13
Sell800
Shulman Joseph
Chief Technical Officer · Common Stock · 2026-08-13
Exercise2.02K
Shulman Joseph
Chief Technical Officer · Stock Options (Right to Buy) · 2026-08-13
Exercise2.02K
Shulman Joseph
Chief Technical Officer · Common Stock · 2026-08-13
Sell5.08K
Garfield Alastair
Chief Scientific Officer · Common Stock · 2026-08-13
Sell2.01K
Lee Jennifer Kayden
EVP, Head of North America · Common Stock · 2026-08-13
Exercise35K

SEC filings

EDGAR filings in RYTM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.